{"gene":"NOBOX","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":2002,"finding":"NOBOX (newborn ovary homeobox gene) is preferentially expressed in primordial and growing oocytes, encodes a homeobox protein, and is one of the first homeobox genes identified as preferentially expressed during mammalian folliculogenesis.","method":"Northern blot, RT-PCR, in situ hybridization, cDNA cloning and genomic characterization","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization by in situ hybridization; single lab but multiple orthogonal methods","pmids":["11804785"],"is_preprint":false},{"year":2006,"finding":"NOBOX binds specific DNA sequences (NOBOX binding elements: TAATTG, TAGTTG, TAATTA) with high affinity, and directly activates transcription of Pou5f1 and Gdf9 by binding NBEs in their promoters, as shown by CAST assay, EMSA, luciferase reporter assays, and chromatin immunoprecipitation.","method":"CAST (cyclic amplification of sequence target) assay, EMSA, luciferase reporter assay, chromatin immunoprecipitation (ChIP)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including ChIP and in vitro DNA binding with mutagenesis, single lab but strong evidence","pmids":["16997917"],"is_preprint":false},{"year":2007,"finding":"The NOBOX missense mutation p.Arg355His in the homeobox domain disrupts NOBOX homeodomain binding to the NOBOX DNA-binding element (NBE) and exerts a dominant negative effect on wild-type NOBOX DNA binding, demonstrating that homeodomain integrity is required for DNA binding.","method":"EMSA (electrophoretic mobility shift assay) with mutant vs. wild-type protein","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro biochemical assay with mutant and wild-type protein comparison","pmids":["17701902"],"is_preprint":false},{"year":2007,"finding":"Nobox acts as a transcriptional activator of oocyte-specific genes; its deficiency leads to downregulation of 74% of oocyte-preferentially expressed genes including Pou5f1 (Oct4), Sall4, Astl, Jag1, Oosp1, Fetub, and Rspo2, while the male-determining gene Dmrt1 is upregulated, placing Nobox as a key activator of oocyte gene expression and suppressor of male-determining gene expression.","method":"Affymetrix microarray of Nobox knockout vs. wild-type newborn ovaries; protein-binding microarray to identify NOBOX-bound promoter motifs","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 2 — genome-wide KO expression profiling combined with protein-binding microarray, strong evidence for activator role","pmids":["17494914"],"is_preprint":false},{"year":2010,"finding":"Nobox directly regulates the transcription of Pad6 (peptidylarginine deiminase 6) in oocytes by binding a NOBOX DNA-binding element (NBE, TAATTA) within the Pad6 promoter, as demonstrated by sequence-specific binding and luciferase reporter overexpression assays.","method":"EMSA, luciferase reporter assay, RT-PCR in Nobox-null ovaries","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA plus reporter assay plus KO gene expression data, single lab","pmids":["20659469"],"is_preprint":false},{"year":2010,"finding":"Bovine NOBOX is a maternal-effect transcription factor required for embryonic development to the blastocyst stage; its depletion in early bovine embryos reduces expression of genes involved in embryonic genome activation, pluripotency genes (POU5F1/OCT4, NANOG), and decreases inner cell mass cell number.","method":"siRNA knockdown in bovine embryos, RT-PCR, Western blot, blastocyst cell counting","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD with defined developmental phenotype and multiple molecular readouts, single lab","pmids":["21193554"],"is_preprint":false},{"year":2011,"finding":"NOBOX mutations (nonsense p.R303X and missense p.G91W, p.R117W, p.S342T, p.V350L) compromise the ability of NOBOX protein to bind and transactivate the GDF9 promoter in transfected cells, consistent with haploinsufficiency as the disease mechanism in humans.","method":"Luciferase reporter/transactivation assay in transfected cells with mutant NOBOX constructs","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 — functional transactivation assay with multiple mutants, single lab","pmids":["21837770"],"is_preprint":false},{"year":2011,"finding":"Nobox deficiency in mice causes defects in germ cell cyst breakdown and impairs somatic cell invasion, leading to formation of syncytial follicles (with abnormal adherens junctions between unseparated oocytes) instead of primordial follicles, indicating faulty somatic-germ cell signaling as the mechanism of premature ovarian failure.","method":"Electron microscopy ultrastructural analysis of Nobox-deficient mouse ovaries","journal":"Journal of assisted reproduction and genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct ultrastructural analysis with loss-of-function model, single lab","pmids":["21369782"],"is_preprint":false},{"year":2011,"finding":"MicroRNA miR-196a directly targets and negatively regulates bovine NOBOX expression during early embryogenesis by binding a microRNA recognition element in the 3' UTR of bovine NOBOX mRNA.","method":"Luciferase 3'-UTR reporter assay with mutant binding site, ectopic expression in HeLa cells, miR-196a mimic injection in bovine embryos with mRNA and protein quantification","journal":"BMC developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 — reconstituted miRNA-target interaction with mutagenesis validation and functional in vivo confirmation in embryos","pmids":["21548929"],"is_preprint":false},{"year":2013,"finding":"NOBOX protein is expressed in the nucleus of growing oocytes (NSN type) but becomes almost undetectable in developmentally competent SN oocytes beginning at 61-70 µm, indicating dynamic nuclear localization linked to developmental competence.","method":"Immunofluorescence and qRT-PCR across oocyte size classes and chromatin configuration (NSN/SN)","journal":"The International journal of developmental biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization experiment across developmental stages with correlation to competence, single lab","pmids":["23585350"],"is_preprint":false},{"year":2014,"finding":"NOBOX directly regulates KIT-L (KITLG) as a novel target gene; POI-associated NOBOX mutations (p.Gly91Thr, p.Gly111Arg, p.Arg117Trp, p.Lys371Thr, p.Pro619Leu) are deleterious for transactivation of both the GDF9 and KIT-L promoters.","method":"Luciferase reporter assay on GDF9 and KIT-L promoters with mutant NOBOX constructs in transfected cells","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — functional transactivation assay on two promoters with multiple mutants, single lab","pmids":["25514101"],"is_preprint":false},{"year":2015,"finding":"A novel NOBOX isoform expressed in the human fetal ovary is capable of upregulating the GDF9 promoter in luciferase reporter assays, indicating isoform-specific transcriptional regulatory activity.","method":"qRT-PCR, reporter assay with GDF9 promoter driven by fetal ovary NOBOX isoform","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay with novel isoform, single lab, single method","pmids":["25790371"],"is_preprint":false},{"year":2016,"finding":"NOBOX variants associated with POI (p.R44L, p.G91W, p.G111R, p.G152R, p.K273*, p.R449*, p.D452N) display functional impairments including defects in transcriptional activity, autophagosomal degradation, impaired nuclear localization, and protein instability; several variants retain the ability to interact with FOXL2 in intracellular aggregates.","method":"Immunolocalization, Western blot, transcriptional assays in HEK293T/CHO cells; co-localization with FOXL2","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal functional assays including localization and interaction studies, single lab","pmids":["27798098"],"is_preprint":false},{"year":2016,"finding":"A homozygous NOBOX truncating variant (chr7:144098161delC) causes loss of transcriptional activation of GDF9 and other oocyte-related genes, and the truncated NOBOX protein loses its ability to induce G2/M cell cycle arrest.","method":"Luciferase reporter assay (GDF9 promoter), qRT-PCR of target genes, cell cycle analysis","journal":"Human reproduction","confidence":"Medium","confidence_rationale":"Tier 2 — multiple functional assays including cell cycle analysis and transcriptional assay, single lab","pmids":["27836978"],"is_preprint":false},{"year":2017,"finding":"RSPO2 is a direct transcriptional target of NOBOX; NOBOX binding elements are present in the RSPO2 promoter and NOBOX transactivates RSPO2 promoter-driven reporter constructs.","method":"Luciferase reporter assay with RSPO2 promoter, identification of NBE in RSPO2 promoter","journal":"Journal of ovarian research","confidence":"Medium","confidence_rationale":"Tier 3 — single reporter assay with promoter analysis, single lab","pmids":["28743298"],"is_preprint":false},{"year":2019,"finding":"In Xenopus, a Nobox-binding element (NBE) in the proximal promoter of hb4 is essential for oocyte-specific transcriptional activation; Nobox expressed in the ovary drives hb4 transcription through this NBE.","method":"Deletion analysis, site-directed mutagenesis, luciferase reporter assay, transgenic reporter analysis in Xenopus tropicalis","journal":"Zygote","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis of binding element plus reporter assay plus transgenic validation, single lab; ortholog context","pmids":["31250783"],"is_preprint":false},{"year":2022,"finding":"In zebrafish, loss of Nobox allows primary follicle formation from cystic oocytes but prevents further follicle development beyond perinucleolar stage, resulting in all-male phenotype due to failure to maintain ovarian differentiation.","method":"CRISPR/Cas9 knockout in zebrafish, histological and gonadal phenotype analysis","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 — clean CRISPR KO with defined developmental phenotype, single lab, ortholog","pmids":["35157068"],"is_preprint":false},{"year":2023,"finding":"In zebrafish, double mutant epistasis (nobox-/-;dmrt1-/-) shows that Nobox is required for follicle growth beyond the previtellogenic stage; Nobox loss reduces ovarian aromatase (cyp19a1a) expression and serum estradiol, and estradiol treatment rescues vitellogenic growth arrest, placing Nobox upstream of estrogen signaling via Gdf9/Bmp15 regulation.","method":"Genetic epistasis (double mutant), serum estradiol quantification, estradiol rescue experiment, gene expression analysis","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with hormonal rescue experiment, multiple orthogonal methods, clear pathway placement","pmids":["37990081"],"is_preprint":false},{"year":2023,"finding":"Mouse NOBOX is sumoylated by SUMO2/3 at a non-consensus site K97; mutation of K97 (NOBOXK97R) increases NOBOX transcriptional activity on the Gdf9 promoter but has no effect on the Pou5f1 promoter, while double mutant NOBOXK97R/K125R shows loss of mono-SUMO2/3 conjugation and altered higher-molecular-weight modifications, indicating sumoylation differentially regulates NOBOX target gene activation.","method":"SUMO mutagenesis, Western blot for sumoylated species, luciferase reporter assay on Gdf9 and Pou5f1 promoters","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — PTM identification by mutagenesis with functional reporter assays, single lab","pmids":["36607631"],"is_preprint":false}],"current_model":"NOBOX is an oocyte-specific homeodomain transcription factor that binds NOBOX DNA-binding elements (TAATTG/TAGTTG/TAATTA) in promoters of oocyte-specific genes (Gdf9, Pou5f1, Pad6, KIT-L, Rspo2) to drive their transcription, is regulated post-translationally by SUMO2/3-conjugation at K97 which modulates its target selectivity, is negatively regulated post-transcriptionally by miR-196a during embryogenesis, acts upstream of estrogen signaling (via Gdf9/Bmp15 and aromatase) to sustain follicle growth, and is required for germ cell cyst breakdown and primordial follicle formation, such that loss-of-function mutations cause premature ovarian insufficiency through haploinsufficiency or biallelic mechanisms."},"narrative":{"teleology":[{"year":2002,"claim":"Identifying NOBOX as one of the first homeobox genes preferentially expressed in oocytes during folliculogenesis established that a homeodomain transcription factor marks the earliest stages of follicle development.","evidence":"Northern blot, RT-PCR, in situ hybridization, and cDNA cloning in mouse ovary","pmids":["11804785"],"confidence":"Medium","gaps":["No target genes or DNA-binding specificity defined","No loss-of-function phenotype yet described"]},{"year":2006,"claim":"Demonstrating that NOBOX binds specific NBE motifs and directly activates Gdf9 and Pou5f1 promoters resolved how this oocyte transcription factor controls key oocyte-specific genes at the molecular level.","evidence":"CAST assay for consensus motif, EMSA, ChIP, and luciferase reporter assays","pmids":["16997917"],"confidence":"High","gaps":["Genome-wide target repertoire not yet characterized","In vivo occupancy data limited to ChIP on two promoters"]},{"year":2007,"claim":"Genome-wide profiling of Nobox-null ovaries revealed that NOBOX activates ~74% of oocyte-specific genes and suppresses male-determining Dmrt1, establishing it as a master regulator of oocyte identity rather than a narrow transcriptional activator, while the R355H mutation showed that homeodomain integrity is essential for DNA binding and can exert dominant-negative effects.","evidence":"Microarray of Nobox KO vs. WT newborn ovaries; EMSA with R355H mutant protein","pmids":["17494914","17701902"],"confidence":"High","gaps":["Direct vs. indirect transcriptional targets not distinguished genome-wide","Mechanism of Dmrt1 derepression unknown"]},{"year":2010,"claim":"Extension of the NOBOX target gene repertoire to Pad6 and demonstration of maternal-effect roles in bovine embryonic genome activation showed that NOBOX function extends beyond folliculogenesis into early embryogenesis.","evidence":"EMSA/reporter assays on Pad6 promoter; siRNA knockdown in bovine embryos with developmental phenotype analysis","pmids":["20659469","21193554"],"confidence":"Medium","gaps":["Maternal-effect function shown only in bovine system","Whether NOBOX regulates embryonic genome activation in mice not tested"]},{"year":2011,"claim":"Three advances—functional impairment of POI-associated mutations on GDF9 transactivation, ultrastructural demonstration that Nobox deficiency disrupts germ cell cyst breakdown via faulty somatic–germ cell signaling, and identification of miR-196a as a post-transcriptional regulator—established the cellular and disease-level consequences of NOBOX loss and its regulatory inputs.","evidence":"Reporter assays with POI mutants; electron microscopy of Nobox-null ovaries; 3′-UTR reporter assays with miR-196a plus embryo injection","pmids":["21837770","21369782","21548929"],"confidence":"High","gaps":["Mechanism linking NOBOX targets to somatic cell invasion not identified","miR-196a regulation validated only in bovine system","In vivo haploinsufficiency vs. dominant-negative distinction in human patients unresolved"]},{"year":2014,"claim":"Identification of KIT-L (KITLG) as a direct NOBOX target explained how NOBOX coordinates oocyte–somatic cell communication, since KIT-L signals from oocytes to granulosa cells.","evidence":"Luciferase reporter assay on KIT-L promoter with WT and POI-mutant NOBOX","pmids":["25514101"],"confidence":"Medium","gaps":["No ChIP validation of NOBOX occupancy at KITLG promoter in vivo","Functional relevance of NOBOX-driven KIT-L for follicle survival not tested in animal model"]},{"year":2016,"claim":"Systematic functional characterization of multiple POI-associated NOBOX variants revealed heterogeneous molecular mechanisms—protein instability, autophagosomal degradation, nuclear mislocalization, and aggregation with FOXL2—explaining allelic heterogeneity in disease severity.","evidence":"Immunolocalization, Western blot, transcriptional assays, and FOXL2 co-localization in HEK293T/CHO cells","pmids":["27798098","27836978"],"confidence":"Medium","gaps":["FOXL2–NOBOX interaction not validated by co-IP or structural data","Autophagosomal targeting mechanism not defined","Cell cycle arrest function of NOBOX not confirmed in oocytes"]},{"year":2022,"claim":"CRISPR knockout of nobox in zebrafish showed that while primary follicle formation can proceed without Nobox, subsequent follicle growth and ovarian identity maintenance require it, resulting in sex reversal to male.","evidence":"CRISPR/Cas9 KO in zebrafish with histological and gonadal phenotype analysis","pmids":["35157068"],"confidence":"Medium","gaps":["Whether sex reversal mechanism is conserved in mammals is unknown","Direct transcriptional targets in zebrafish ovary not identified"]},{"year":2023,"claim":"Genetic epistasis and estradiol rescue placed NOBOX upstream of estrogen signaling (via Gdf9/Bmp15→aromatase) for sustaining vitellogenic follicle growth, while SUMO2/3 conjugation at K97 was shown to differentially modulate NOBOX target selectivity, adding a post-translational regulatory layer.","evidence":"nobox/dmrt1 double mutant epistasis with estradiol rescue in zebrafish; SUMO mutagenesis with reporter assays on Gdf9 and Pou5f1 promoters in mouse","pmids":["37990081","36607631"],"confidence":"High","gaps":["SUMO-dependent selectivity mechanism (cofactor recruitment vs. chromatin context) not resolved","Whether sumoylation status changes during follicle development in vivo is untested","Aromatase regulation by NOBOX not confirmed in mammals"]},{"year":null,"claim":"Genome-wide direct occupancy mapping (e.g., ChIP-seq) in oocytes, structural basis of NBE recognition and target selectivity, the functional relationship between NOBOX and FOXL2, and whether sumoylation regulates NOBOX in vivo during folliculogenesis remain major open questions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No ChIP-seq in primary oocytes","No crystal or cryo-EM structure of NOBOX homeodomain–DNA complex","NOBOX–FOXL2 functional interaction not validated by reciprocal biochemistry","In vivo significance of SUMO modification untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,2,3,4]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,3,4,6,10,13,14,18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,9,12]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,7,16,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,6,12,13]}],"complexes":[],"partners":["FOXL2","SUMO2","SUMO3"],"other_free_text":[]},"mechanistic_narrative":"NOBOX is an oocyte-specific homeodomain transcription factor essential for folliculogenesis, germ cell cyst breakdown, and maintenance of ovarian identity. It binds NOBOX DNA-binding elements (NBEs: TAATTG/TAGTTG/TAATTA) in promoters of oocyte-specific genes—including Gdf9, Pou5f1, Pad6, KIT-L, and Rspo2—to activate their transcription, and its deficiency causes downregulation of ~74% of oocyte-preferentially expressed genes while derepressing male-determining genes such as Dmrt1 [PMID:16997917, PMID:17494914, PMID:25514101]. NOBOX acts upstream of estrogen signaling by driving Gdf9/Bmp15 expression to sustain aromatase activity and follicle growth beyond the previtellogenic stage, as demonstrated by estradiol rescue of nobox-null zebrafish [PMID:37990081]. Its transcriptional output is modulated post-translationally by SUMO2/3 conjugation at K97, which selectively attenuates activation of the Gdf9 but not the Pou5f1 promoter, and post-transcriptionally by miR-196a during early embryogenesis [PMID:36607631, PMID:21548929]. Loss-of-function NOBOX mutations—both heterozygous and biallelic—cause premature ovarian insufficiency in humans through haploinsufficiency, dominant-negative effects on DNA binding, protein instability, or mislocalization [PMID:17701902, PMID:21837770, PMID:27798098]."},"prefetch_data":{"uniprot":{"accession":"O60393","full_name":"Homeobox protein NOBOX","aliases":[],"length_aa":691,"mass_kda":73.9,"function":"Transcription factor which may play a role in oogenesis. Binds preferentially to the DNA sequences 5'-TAATTG-3', 5'-TAGTTG-3' and 5'-TAATTA-3'","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O60393/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NOBOX","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":77,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NOBOX","total_profiled":1310},"omim":[{"mim_id":"620360","title":"TETRAPEPTIDE REPEAT HOMEOBOX 2; TPRX2","url":"https://www.omim.org/entry/620360"},{"mim_id":"618700","title":"CYTOPLASMIC POLYADENYLATED HOMEOBOX-LIKE; CPHXL","url":"https://www.omim.org/entry/618700"},{"mim_id":"618698","title":"DOUBLE HOMEOBOX B; DUXB","url":"https://www.omim.org/entry/618698"},{"mim_id":"618014","title":"PREMATURE OVARIAN FAILURE 14; POF14","url":"https://www.omim.org/entry/618014"},{"mim_id":"617265","title":"POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 9; KCTD9","url":"https://www.omim.org/entry/617265"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NOBOX"},"hgnc":{"alias_symbol":["OG2","Og2x"],"prev_symbol":[]},"alphafold":{"accession":"O60393","domains":[{"cath_id":"1.10.10.60","chopping":"289-313_343-362","consensus_level":"medium","plddt":82.8147,"start":289,"end":362}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60393","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60393-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60393-F1-predicted_aligned_error_v6.png","plddt_mean":47.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NOBOX","jax_strain_url":"https://www.jax.org/strain/search?query=NOBOX"},"sequence":{"accession":"O60393","fasta_url":"https://rest.uniprot.org/uniprotkb/O60393.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60393/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60393"}},"corpus_meta":[{"pmid":"17701902","id":"PMC_17701902","title":"NOBOX homeobox mutation causes premature ovarian failure.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17701902","citation_count":186,"is_preprint":false},{"pmid":"11804785","id":"PMC_11804785","title":"Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11804785","citation_count":130,"is_preprint":false},{"pmid":"17494914","id":"PMC_17494914","title":"Microarray analyses of newborn mouse ovaries lacking Nobox.","date":"2007","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/17494914","citation_count":108,"is_preprint":false},{"pmid":"21837770","id":"PMC_21837770","title":"Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort.","date":"2011","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/21837770","citation_count":77,"is_preprint":false},{"pmid":"16997917","id":"PMC_16997917","title":"Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16997917","citation_count":75,"is_preprint":false},{"pmid":"21369782","id":"PMC_21369782","title":"Premature ovarian failure in nobox-deficient mice is caused by defects in somatic cell invasion and germ cell cyst breakdown.","date":"2011","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21369782","citation_count":62,"is_preprint":false},{"pmid":"21548929","id":"PMC_21548929","title":"MicroRNA-196a regulates bovine newborn ovary homeobox gene (NOBOX) expression during early embryogenesis.","date":"2011","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21548929","citation_count":61,"is_preprint":false},{"pmid":"16597639","id":"PMC_16597639","title":"cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles.","date":"2006","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/16597639","citation_count":55,"is_preprint":false},{"pmid":"27836978","id":"PMC_27836978","title":"A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency.","date":"2016","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27836978","citation_count":50,"is_preprint":false},{"pmid":"18930203","id":"PMC_18930203","title":"Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure.","date":"2008","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/18930203","citation_count":47,"is_preprint":false},{"pmid":"25514101","id":"PMC_25514101","title":"New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression.","date":"2014","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25514101","citation_count":43,"is_preprint":false},{"pmid":"21193554","id":"PMC_21193554","title":"A novel functional role for the oocyte-specific transcription factor newborn ovary homeobox (NOBOX) during early embryonic development in cattle.","date":"2010","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21193554","citation_count":43,"is_preprint":false},{"pmid":"25790371","id":"PMC_25790371","title":"GDF9 is transiently expressed in oocytes before follicle formation in the human fetal ovary and is regulated by a novel NOBOX transcript.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25790371","citation_count":39,"is_preprint":false},{"pmid":"19480014","id":"PMC_19480014","title":"Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.","date":"2009","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/19480014","citation_count":35,"is_preprint":false},{"pmid":"15950662","id":"PMC_15950662","title":"Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure.","date":"2005","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/15950662","citation_count":33,"is_preprint":false},{"pmid":"27798098","id":"PMC_27798098","title":"Impaired protein stability and nuclear localization of NOBOX variants associated with premature ovarian insufficiency.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27798098","citation_count":23,"is_preprint":false},{"pmid":"26848058","id":"PMC_26848058","title":"NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26848058","citation_count":22,"is_preprint":false},{"pmid":"23585350","id":"PMC_23585350","title":"The NOBOX protein becomes undetectable in developmentally competent antral and ovulated oocytes.","date":"2013","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23585350","citation_count":18,"is_preprint":false},{"pmid":"22670762","id":"PMC_22670762","title":"Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.","date":"2013","source":"Protein and peptide letters","url":"https://pubmed.ncbi.nlm.nih.gov/22670762","citation_count":18,"is_preprint":false},{"pmid":"29067606","id":"PMC_29067606","title":"A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failure.","date":"2017","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/29067606","citation_count":18,"is_preprint":false},{"pmid":"20659469","id":"PMC_20659469","title":"The oocyte-specific transcription factor, Nobox, regulates the expression of Pad6, a peptidylarginine deiminase in the oocyte.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20659469","citation_count":16,"is_preprint":false},{"pmid":"35157068","id":"PMC_35157068","title":"Loss of Nobox prevents ovarian differentiation from juvenile ovaries in zebrafish.","date":"2022","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/35157068","citation_count":15,"is_preprint":false},{"pmid":"37990081","id":"PMC_37990081","title":"Genetic evidence for differential functions of figla and nobox in zebrafish ovarian differentiation and folliculogenesis.","date":"2023","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/37990081","citation_count":13,"is_preprint":false},{"pmid":"11685649","id":"PMC_11685649","title":"Expression of mouse osteocalcin transcripts, OG1 and OG2, is differently regulated in bone tissues and osteoblast cultures.","date":"2001","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11685649","citation_count":13,"is_preprint":false},{"pmid":"23936842","id":"PMC_23936842","title":"High-yield soluble expression and simple purification of the antimicrobial peptide OG2 using the intein system in Escherichia coli.","date":"2013","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/23936842","citation_count":12,"is_preprint":false},{"pmid":"28567625","id":"PMC_28567625","title":"Biodegradation of α-endosulfan via hydrolysis pathway by Stenotrophomonas maltophilia OG2.","date":"2017","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/28567625","citation_count":10,"is_preprint":false},{"pmid":"28743298","id":"PMC_28743298","title":"R-spondin2, a novel target of NOBOX: identification of variants in a cohort of women with primary ovarian insufficiency.","date":"2017","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/28743298","citation_count":9,"is_preprint":false},{"pmid":"34480423","id":"PMC_34480423","title":"Compound heterozygous null mutations of NOBOX in sisters with delayed puberty and primary amenorrhea.","date":"2021","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34480423","citation_count":8,"is_preprint":false},{"pmid":"36607631","id":"PMC_36607631","title":"Sumoylation regulates functional properties of the oocyte transcription factors SOHLH1 and NOBOX.","date":"2023","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/36607631","citation_count":7,"is_preprint":false},{"pmid":"37921973","id":"PMC_37921973","title":"NOBOX gene variants in premature ovarian insufficiency: ethnicity-dependent insights.","date":"2023","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37921973","citation_count":6,"is_preprint":false},{"pmid":"35257353","id":"PMC_35257353","title":"Hypo-Hydroxymethylation of Nobox is Associated with Ovarian Dysfunction in Rat Offspring Exposed to Prenatal Hypoxia.","date":"2022","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/35257353","citation_count":4,"is_preprint":false},{"pmid":"23078866","id":"PMC_23078866","title":"A reporter promoter assay confirmed the role of a distal promoter NOBOX binding element in enhancing expression of GDF9 gene in buffalo oocytes.","date":"2012","source":"Animal reproduction science","url":"https://pubmed.ncbi.nlm.nih.gov/23078866","citation_count":4,"is_preprint":false},{"pmid":"21777853","id":"PMC_21777853","title":"Establishment of novel embryonic stem (ES) cell lines from OG2/rtTA blastocysts.","date":"2011","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/21777853","citation_count":3,"is_preprint":false},{"pmid":"40246288","id":"PMC_40246288","title":"Reclassifying NOBOX variants in primary ovarian insufficiency cases with a corrected gene model and a novel quantitative framework.","date":"2025","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/40246288","citation_count":2,"is_preprint":false},{"pmid":"38523712","id":"PMC_38523712","title":"Association between polymorphisms in NOBOX and litter size traits in Xiangsu pigs.","date":"2024","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/38523712","citation_count":2,"is_preprint":false},{"pmid":"19938448","id":"PMC_19938448","title":"Cloning and characterization of porcine NOBOX gene.","date":"2009","source":"Sheng wu gong cheng xue bao = Chinese journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/19938448","citation_count":2,"is_preprint":false},{"pmid":"31250783","id":"PMC_31250783","title":"Specific activation of the hb4 gene in the Xenopus oocyte through a Nobox-binding element located at the proximal promoter sequence.","date":"2019","source":"Zygote (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31250783","citation_count":0,"is_preprint":false},{"pmid":"41324758","id":"PMC_41324758","title":"Primary ovarian insufficiency due to homozygous variants in the homeobox transcription factor NOBOX.","date":"2025","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/41324758","citation_count":0,"is_preprint":false},{"pmid":"41903788","id":"PMC_41903788","title":"Deletion of the glucocorticoid receptor in osteoblasts and osteocytes drives trabecular bone loss in Col2.3-Cre and OG2-Cre knockout mice.","date":"2026","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/41903788","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19832,"output_tokens":4205,"usd":0.061285},"stage2":{"model":"claude-opus-4-6","input_tokens":7677,"output_tokens":2650,"usd":0.156952},"total_usd":0.218237,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"NOBOX (newborn ovary homeobox gene) is preferentially expressed in primordial and growing oocytes, encodes a homeobox protein, and is one of the first homeobox genes identified as preferentially expressed during mammalian folliculogenesis.\",\n      \"method\": \"Northern blot, RT-PCR, in situ hybridization, cDNA cloning and genomic characterization\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by in situ hybridization; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"11804785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NOBOX binds specific DNA sequences (NOBOX binding elements: TAATTG, TAGTTG, TAATTA) with high affinity, and directly activates transcription of Pou5f1 and Gdf9 by binding NBEs in their promoters, as shown by CAST assay, EMSA, luciferase reporter assays, and chromatin immunoprecipitation.\",\n      \"method\": \"CAST (cyclic amplification of sequence target) assay, EMSA, luciferase reporter assay, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including ChIP and in vitro DNA binding with mutagenesis, single lab but strong evidence\",\n      \"pmids\": [\"16997917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The NOBOX missense mutation p.Arg355His in the homeobox domain disrupts NOBOX homeodomain binding to the NOBOX DNA-binding element (NBE) and exerts a dominant negative effect on wild-type NOBOX DNA binding, demonstrating that homeodomain integrity is required for DNA binding.\",\n      \"method\": \"EMSA (electrophoretic mobility shift assay) with mutant vs. wild-type protein\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro biochemical assay with mutant and wild-type protein comparison\",\n      \"pmids\": [\"17701902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nobox acts as a transcriptional activator of oocyte-specific genes; its deficiency leads to downregulation of 74% of oocyte-preferentially expressed genes including Pou5f1 (Oct4), Sall4, Astl, Jag1, Oosp1, Fetub, and Rspo2, while the male-determining gene Dmrt1 is upregulated, placing Nobox as a key activator of oocyte gene expression and suppressor of male-determining gene expression.\",\n      \"method\": \"Affymetrix microarray of Nobox knockout vs. wild-type newborn ovaries; protein-binding microarray to identify NOBOX-bound promoter motifs\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide KO expression profiling combined with protein-binding microarray, strong evidence for activator role\",\n      \"pmids\": [\"17494914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Nobox directly regulates the transcription of Pad6 (peptidylarginine deiminase 6) in oocytes by binding a NOBOX DNA-binding element (NBE, TAATTA) within the Pad6 promoter, as demonstrated by sequence-specific binding and luciferase reporter overexpression assays.\",\n      \"method\": \"EMSA, luciferase reporter assay, RT-PCR in Nobox-null ovaries\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA plus reporter assay plus KO gene expression data, single lab\",\n      \"pmids\": [\"20659469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Bovine NOBOX is a maternal-effect transcription factor required for embryonic development to the blastocyst stage; its depletion in early bovine embryos reduces expression of genes involved in embryonic genome activation, pluripotency genes (POU5F1/OCT4, NANOG), and decreases inner cell mass cell number.\",\n      \"method\": \"siRNA knockdown in bovine embryos, RT-PCR, Western blot, blastocyst cell counting\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined developmental phenotype and multiple molecular readouts, single lab\",\n      \"pmids\": [\"21193554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NOBOX mutations (nonsense p.R303X and missense p.G91W, p.R117W, p.S342T, p.V350L) compromise the ability of NOBOX protein to bind and transactivate the GDF9 promoter in transfected cells, consistent with haploinsufficiency as the disease mechanism in humans.\",\n      \"method\": \"Luciferase reporter/transactivation assay in transfected cells with mutant NOBOX constructs\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional transactivation assay with multiple mutants, single lab\",\n      \"pmids\": [\"21837770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nobox deficiency in mice causes defects in germ cell cyst breakdown and impairs somatic cell invasion, leading to formation of syncytial follicles (with abnormal adherens junctions between unseparated oocytes) instead of primordial follicles, indicating faulty somatic-germ cell signaling as the mechanism of premature ovarian failure.\",\n      \"method\": \"Electron microscopy ultrastructural analysis of Nobox-deficient mouse ovaries\",\n      \"journal\": \"Journal of assisted reproduction and genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct ultrastructural analysis with loss-of-function model, single lab\",\n      \"pmids\": [\"21369782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MicroRNA miR-196a directly targets and negatively regulates bovine NOBOX expression during early embryogenesis by binding a microRNA recognition element in the 3' UTR of bovine NOBOX mRNA.\",\n      \"method\": \"Luciferase 3'-UTR reporter assay with mutant binding site, ectopic expression in HeLa cells, miR-196a mimic injection in bovine embryos with mRNA and protein quantification\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted miRNA-target interaction with mutagenesis validation and functional in vivo confirmation in embryos\",\n      \"pmids\": [\"21548929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NOBOX protein is expressed in the nucleus of growing oocytes (NSN type) but becomes almost undetectable in developmentally competent SN oocytes beginning at 61-70 µm, indicating dynamic nuclear localization linked to developmental competence.\",\n      \"method\": \"Immunofluorescence and qRT-PCR across oocyte size classes and chromatin configuration (NSN/SN)\",\n      \"journal\": \"The International journal of developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization experiment across developmental stages with correlation to competence, single lab\",\n      \"pmids\": [\"23585350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NOBOX directly regulates KIT-L (KITLG) as a novel target gene; POI-associated NOBOX mutations (p.Gly91Thr, p.Gly111Arg, p.Arg117Trp, p.Lys371Thr, p.Pro619Leu) are deleterious for transactivation of both the GDF9 and KIT-L promoters.\",\n      \"method\": \"Luciferase reporter assay on GDF9 and KIT-L promoters with mutant NOBOX constructs in transfected cells\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional transactivation assay on two promoters with multiple mutants, single lab\",\n      \"pmids\": [\"25514101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A novel NOBOX isoform expressed in the human fetal ovary is capable of upregulating the GDF9 promoter in luciferase reporter assays, indicating isoform-specific transcriptional regulatory activity.\",\n      \"method\": \"qRT-PCR, reporter assay with GDF9 promoter driven by fetal ovary NOBOX isoform\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay with novel isoform, single lab, single method\",\n      \"pmids\": [\"25790371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NOBOX variants associated with POI (p.R44L, p.G91W, p.G111R, p.G152R, p.K273*, p.R449*, p.D452N) display functional impairments including defects in transcriptional activity, autophagosomal degradation, impaired nuclear localization, and protein instability; several variants retain the ability to interact with FOXL2 in intracellular aggregates.\",\n      \"method\": \"Immunolocalization, Western blot, transcriptional assays in HEK293T/CHO cells; co-localization with FOXL2\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays including localization and interaction studies, single lab\",\n      \"pmids\": [\"27798098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A homozygous NOBOX truncating variant (chr7:144098161delC) causes loss of transcriptional activation of GDF9 and other oocyte-related genes, and the truncated NOBOX protein loses its ability to induce G2/M cell cycle arrest.\",\n      \"method\": \"Luciferase reporter assay (GDF9 promoter), qRT-PCR of target genes, cell cycle analysis\",\n      \"journal\": \"Human reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays including cell cycle analysis and transcriptional assay, single lab\",\n      \"pmids\": [\"27836978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RSPO2 is a direct transcriptional target of NOBOX; NOBOX binding elements are present in the RSPO2 promoter and NOBOX transactivates RSPO2 promoter-driven reporter constructs.\",\n      \"method\": \"Luciferase reporter assay with RSPO2 promoter, identification of NBE in RSPO2 promoter\",\n      \"journal\": \"Journal of ovarian research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single reporter assay with promoter analysis, single lab\",\n      \"pmids\": [\"28743298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In Xenopus, a Nobox-binding element (NBE) in the proximal promoter of hb4 is essential for oocyte-specific transcriptional activation; Nobox expressed in the ovary drives hb4 transcription through this NBE.\",\n      \"method\": \"Deletion analysis, site-directed mutagenesis, luciferase reporter assay, transgenic reporter analysis in Xenopus tropicalis\",\n      \"journal\": \"Zygote\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis of binding element plus reporter assay plus transgenic validation, single lab; ortholog context\",\n      \"pmids\": [\"31250783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In zebrafish, loss of Nobox allows primary follicle formation from cystic oocytes but prevents further follicle development beyond perinucleolar stage, resulting in all-male phenotype due to failure to maintain ovarian differentiation.\",\n      \"method\": \"CRISPR/Cas9 knockout in zebrafish, histological and gonadal phenotype analysis\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean CRISPR KO with defined developmental phenotype, single lab, ortholog\",\n      \"pmids\": [\"35157068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In zebrafish, double mutant epistasis (nobox-/-;dmrt1-/-) shows that Nobox is required for follicle growth beyond the previtellogenic stage; Nobox loss reduces ovarian aromatase (cyp19a1a) expression and serum estradiol, and estradiol treatment rescues vitellogenic growth arrest, placing Nobox upstream of estrogen signaling via Gdf9/Bmp15 regulation.\",\n      \"method\": \"Genetic epistasis (double mutant), serum estradiol quantification, estradiol rescue experiment, gene expression analysis\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with hormonal rescue experiment, multiple orthogonal methods, clear pathway placement\",\n      \"pmids\": [\"37990081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mouse NOBOX is sumoylated by SUMO2/3 at a non-consensus site K97; mutation of K97 (NOBOXK97R) increases NOBOX transcriptional activity on the Gdf9 promoter but has no effect on the Pou5f1 promoter, while double mutant NOBOXK97R/K125R shows loss of mono-SUMO2/3 conjugation and altered higher-molecular-weight modifications, indicating sumoylation differentially regulates NOBOX target gene activation.\",\n      \"method\": \"SUMO mutagenesis, Western blot for sumoylated species, luciferase reporter assay on Gdf9 and Pou5f1 promoters\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — PTM identification by mutagenesis with functional reporter assays, single lab\",\n      \"pmids\": [\"36607631\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOBOX is an oocyte-specific homeodomain transcription factor that binds NOBOX DNA-binding elements (TAATTG/TAGTTG/TAATTA) in promoters of oocyte-specific genes (Gdf9, Pou5f1, Pad6, KIT-L, Rspo2) to drive their transcription, is regulated post-translationally by SUMO2/3-conjugation at K97 which modulates its target selectivity, is negatively regulated post-transcriptionally by miR-196a during embryogenesis, acts upstream of estrogen signaling (via Gdf9/Bmp15 and aromatase) to sustain follicle growth, and is required for germ cell cyst breakdown and primordial follicle formation, such that loss-of-function mutations cause premature ovarian insufficiency through haploinsufficiency or biallelic mechanisms.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NOBOX is an oocyte-specific homeodomain transcription factor essential for folliculogenesis, germ cell cyst breakdown, and maintenance of ovarian identity. It binds NOBOX DNA-binding elements (NBEs: TAATTG/TAGTTG/TAATTA) in promoters of oocyte-specific genes—including Gdf9, Pou5f1, Pad6, KIT-L, and Rspo2—to activate their transcription, and its deficiency causes downregulation of ~74% of oocyte-preferentially expressed genes while derepressing male-determining genes such as Dmrt1 [PMID:16997917, PMID:17494914, PMID:25514101]. NOBOX acts upstream of estrogen signaling by driving Gdf9/Bmp15 expression to sustain aromatase activity and follicle growth beyond the previtellogenic stage, as demonstrated by estradiol rescue of nobox-null zebrafish [PMID:37990081]. Its transcriptional output is modulated post-translationally by SUMO2/3 conjugation at K97, which selectively attenuates activation of the Gdf9 but not the Pou5f1 promoter, and post-transcriptionally by miR-196a during early embryogenesis [PMID:36607631, PMID:21548929]. Loss-of-function NOBOX mutations—both heterozygous and biallelic—cause premature ovarian insufficiency in humans through haploinsufficiency, dominant-negative effects on DNA binding, protein instability, or mislocalization [PMID:17701902, PMID:21837770, PMID:27798098].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Identifying NOBOX as one of the first homeobox genes preferentially expressed in oocytes during folliculogenesis established that a homeodomain transcription factor marks the earliest stages of follicle development.\",\n      \"evidence\": \"Northern blot, RT-PCR, in situ hybridization, and cDNA cloning in mouse ovary\",\n      \"pmids\": [\"11804785\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No target genes or DNA-binding specificity defined\", \"No loss-of-function phenotype yet described\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that NOBOX binds specific NBE motifs and directly activates Gdf9 and Pou5f1 promoters resolved how this oocyte transcription factor controls key oocyte-specific genes at the molecular level.\",\n      \"evidence\": \"CAST assay for consensus motif, EMSA, ChIP, and luciferase reporter assays\",\n      \"pmids\": [\"16997917\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target repertoire not yet characterized\", \"In vivo occupancy data limited to ChIP on two promoters\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genome-wide profiling of Nobox-null ovaries revealed that NOBOX activates ~74% of oocyte-specific genes and suppresses male-determining Dmrt1, establishing it as a master regulator of oocyte identity rather than a narrow transcriptional activator, while the R355H mutation showed that homeodomain integrity is essential for DNA binding and can exert dominant-negative effects.\",\n      \"evidence\": \"Microarray of Nobox KO vs. WT newborn ovaries; EMSA with R355H mutant protein\",\n      \"pmids\": [\"17494914\", \"17701902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect transcriptional targets not distinguished genome-wide\", \"Mechanism of Dmrt1 derepression unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extension of the NOBOX target gene repertoire to Pad6 and demonstration of maternal-effect roles in bovine embryonic genome activation showed that NOBOX function extends beyond folliculogenesis into early embryogenesis.\",\n      \"evidence\": \"EMSA/reporter assays on Pad6 promoter; siRNA knockdown in bovine embryos with developmental phenotype analysis\",\n      \"pmids\": [\"20659469\", \"21193554\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Maternal-effect function shown only in bovine system\", \"Whether NOBOX regulates embryonic genome activation in mice not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Three advances—functional impairment of POI-associated mutations on GDF9 transactivation, ultrastructural demonstration that Nobox deficiency disrupts germ cell cyst breakdown via faulty somatic–germ cell signaling, and identification of miR-196a as a post-transcriptional regulator—established the cellular and disease-level consequences of NOBOX loss and its regulatory inputs.\",\n      \"evidence\": \"Reporter assays with POI mutants; electron microscopy of Nobox-null ovaries; 3′-UTR reporter assays with miR-196a plus embryo injection\",\n      \"pmids\": [\"21837770\", \"21369782\", \"21548929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking NOBOX targets to somatic cell invasion not identified\", \"miR-196a regulation validated only in bovine system\", \"In vivo haploinsufficiency vs. dominant-negative distinction in human patients unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of KIT-L (KITLG) as a direct NOBOX target explained how NOBOX coordinates oocyte–somatic cell communication, since KIT-L signals from oocytes to granulosa cells.\",\n      \"evidence\": \"Luciferase reporter assay on KIT-L promoter with WT and POI-mutant NOBOX\",\n      \"pmids\": [\"25514101\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No ChIP validation of NOBOX occupancy at KITLG promoter in vivo\", \"Functional relevance of NOBOX-driven KIT-L for follicle survival not tested in animal model\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Systematic functional characterization of multiple POI-associated NOBOX variants revealed heterogeneous molecular mechanisms—protein instability, autophagosomal degradation, nuclear mislocalization, and aggregation with FOXL2—explaining allelic heterogeneity in disease severity.\",\n      \"evidence\": \"Immunolocalization, Western blot, transcriptional assays, and FOXL2 co-localization in HEK293T/CHO cells\",\n      \"pmids\": [\"27798098\", \"27836978\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FOXL2–NOBOX interaction not validated by co-IP or structural data\", \"Autophagosomal targeting mechanism not defined\", \"Cell cycle arrest function of NOBOX not confirmed in oocytes\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"CRISPR knockout of nobox in zebrafish showed that while primary follicle formation can proceed without Nobox, subsequent follicle growth and ovarian identity maintenance require it, resulting in sex reversal to male.\",\n      \"evidence\": \"CRISPR/Cas9 KO in zebrafish with histological and gonadal phenotype analysis\",\n      \"pmids\": [\"35157068\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether sex reversal mechanism is conserved in mammals is unknown\", \"Direct transcriptional targets in zebrafish ovary not identified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Genetic epistasis and estradiol rescue placed NOBOX upstream of estrogen signaling (via Gdf9/Bmp15→aromatase) for sustaining vitellogenic follicle growth, while SUMO2/3 conjugation at K97 was shown to differentially modulate NOBOX target selectivity, adding a post-translational regulatory layer.\",\n      \"evidence\": \"nobox/dmrt1 double mutant epistasis with estradiol rescue in zebrafish; SUMO mutagenesis with reporter assays on Gdf9 and Pou5f1 promoters in mouse\",\n      \"pmids\": [\"37990081\", \"36607631\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SUMO-dependent selectivity mechanism (cofactor recruitment vs. chromatin context) not resolved\", \"Whether sumoylation status changes during follicle development in vivo is untested\", \"Aromatase regulation by NOBOX not confirmed in mammals\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Genome-wide direct occupancy mapping (e.g., ChIP-seq) in oocytes, structural basis of NBE recognition and target selectivity, the functional relationship between NOBOX and FOXL2, and whether sumoylation regulates NOBOX in vivo during folliculogenesis remain major open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No ChIP-seq in primary oocytes\", \"No crystal or cryo-EM structure of NOBOX homeodomain–DNA complex\", \"NOBOX–FOXL2 functional interaction not validated by reciprocal biochemistry\", \"In vivo significance of SUMO modification untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 2, 3, 4]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 3, 4, 6, 10, 13, 14, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 9, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [1, 3, 4, 6, 10, 14]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 7, 16, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 6, 12, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FOXL2\",\n      \"SUMO2\",\n      \"SUMO3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}